Element Biosciences by Molly He

Molly He co-founded Element Biosciences in the year 2017. She is also the CEO of the company that caters in the Biotechnology Research industry. The company has raised $277 million Series D in 2024 with more than $680 million till date in funding. Headquartered in San Diego, California, the company a pioneering life science company with specialities Next-Generation Sequencers, DNA, and Biotechnology. It also empowers customers with affordable, high-quality data as well as improved user experience.

Additionally, Molly’s professional life includes Foresite Capital where she worked for an essential 2 years while also giving 7 years of her career to Illumina, working as Senior Director, Protein Engineering and Enzymology. Another organisation where she gave her significant years of professional journey is Sunesis Pharmaceuticals as Senior Scientist/Project Leader, Protein Sciences.